Weekly Legislative Update 6/17/17

revolutionbumperWelcome to this week’s edition of the NORML legislative roundup!

At the Federal level, the biggest news this week was two-fold. First, in a letter made public by Tom Angell of Marijuana Moment, it was revealed that Attorney General Jeff Sessions wrote a private message to Congressional leadership requesting that they lift restrictions on the Department of Justice’s ability to prosecute medical marijuana in states that have legalized. This would overturn years of precedent and could result in the shutdown of lawful state medical programs, depriving patients of the ability to make healthcare decisions with their doctor. This revelation came the day before Deputy Attorney General Rod Rosenstein testified before Congress and stated “The question of whether it’s legal under federal law is resolved because Congress has passed a law — it’s illegal. Scientists have found that there’s no accepted medical use for it.”

Which rolls us right into the second biggest Federal development: the reintroduction of the CARERS Act, which would codify protections for lawful state medical programs. Passage of CARERS 2017 would exempt from federal prosecution those who are engaged in the “production, possession, distribution, dispensation, administration, laboratory testing, recommending use, or delivery of medical marijuana” in instances where these activities comport with state law.

At the state level, New Hampshire Governor Chris Sununu signed HB 157 into law on June 16. The law adds “moderate to severe chronic pain” as a qualifying illness for medical cannabis. The new law takes effect in 60 days.

Following are the bills from around the country that we’ve tracked this week and as always, check http://norml.org/act for legislation pending in your state.

Don’t forget to sign up for our email list and we will keep you posted as these bills and more move through your home state legislature and at the federal level.

Thanks for all you do and keep fighting,
Justin

Priority Alerts

Federal
Join The Caucus: With public support for reforming marijuana laws at an all time high, Reps. Earl Blumenauer (D-OR), Dana Rohrabacher (R-CA), Jared Polis (D-CO), and Don Young (R-AK) earlier this year formed the Congressional Cannabis Caucus to develop and promote sensible cannabis policy reform and work to ease the tension between federal and state cannabis laws.

Click here to email your Member of Congress to urge them to join the Congressional Cannabis Caucus

Protecting Patients: Legislation has been reintroduced in the Senate, The Compassionate Access, Research Expansion, and Respect States (CARERS) Act of 2017, to strengthen protections for those compliant with their state’s medical marijuana laws and to impose various changes to federal law.

Passage of CARERS 2017 exempts from federal prosecution those who are engaged in the “production, possession, distribution, dispensation, administration, laboratory testing, recommending use, or delivery of medical marijuana” in instances where these activities comport with state law. Separate provisions in Act exclude cannabdiol from the federal definition of marijuana, permit VA doctors to authorize medical cannabis access to qualified patients, and remove undue federal barriers to clinical trial research to better assess the safety and efficacy of medical cannabis.

Click here to send a message to your Senators urging them to support and possible co-sponsor the CARERS Act of 2017

Maine
Legislation (LD 764) is before Gov. Paul LePage that will prohibit medical cannabis patients from being denied organ transplants.

The measure “prohibits a transplant evaluator from determining a qualifying patient to be unsuitable to receive an anatomical gift solely because the qualifying patient uses medical marijuana.”

ME resident? Click here to send a message to Gov. LePage urging him to sign the bill. 

Massachusetts
Members of the House put forward amendments to The Regulation and Taxation of Marijuana Act. Among proposed changes to the law would more than double taxes on retail cannabis sales, from 12 percent to as much as 28 percent, strip local control away from municipal voters and unilaterally give local government officials the power to decide whether or not to ban marijuana facilities in their communities, and restrict the kinds of marijuana edibles products that may be sold and purchased by adults.

MA resident? Send a message to your lawmakers telling them to enact Question 4 as passed in a timely manner. 

 

First Meeting Of Trump’s Opioid Commission: Will It Be Effective?

Marijuana medicineToday, the Office of National Drug Control Policy convened its first meeting of President Trump’s “Commission on Combating Drug Addiction and the Opioid Crisis.”

The Commission is tasked with making recommendations for improving the Federal response to opioid misuse and abuse.

Best evidence informs us that medical marijuana access is associated with reduced levels of opioid-related abuse, hospitalization, and mortality. Nonetheless, this administration continues to express skepticism with regard to the safety and efficacy of medical marijuana.

Today in The Hill newspaper, NORML Deputy Director Paul Armentano writes:

With opioid overdose deaths having risen four-fold since 1999, it is imperative that lawmakers and public health experts approach this issue with an open mind and remain willing to entertain all potential alternatives.

For many patients, cannabis provides a safe and effective substitute for the use of opioids and other potentially harmful substances. Committee members should set their political ideologies aside and give strong consideration to this rapidly growing body of scientific evidence.

You can read the full piece in The Hill by clicking here.

It is crucial that our government hear from us. Click here to send a message to the Commission urging them to include medical marijuana as part of any national response to the opioid crisis.

Rates of marijuana use, heavy use, and cannabis use disorder depend on where you live

Adult marijuana use rose significantly in states that passed loosely regulated medical marijuana laws (MMLs) according to a new study. The highest increases were reported among adults ages 26 and over. Little change was found in past-month marijuana use among adolescents or young adults between the ages 18 and 25.

Pennsylvania Governor to AG Sessions: Back Off!

In a recent letter to Attorney General Jeff Sessions, Pennsylvania Governor Tom Wolf wrote a pointed letter regarding the Department of Justice and it’s posturing to implement a crackdown of lawful state medical marijuana programs.

The full letter:

Dear Attorney General Sessions:

Last year, the Pennsylvania passed bipartisan legislation to legalize Medical Marijuana that I was proud to sign into law. The legislation was the result of conversations with Republicans and Democrats and fierce advocacy from families of children who were stricken with terrible illness that could be helped by Medical Marijuana.

We talked to kids who suffer dozens of seizures in a given day. We met veterans who have seen absolute terror and seek relief from the effects of their post-traumatic stress. We approached the responsibility of providing relief to the people of Pennsylvania very thoughtfully.

Since I signed the legislation, we have taken very careful and deliberate steps to implement the law so that those who are suffering can get relief while ensuring that the state is a responsible steward of the program.

Given the bipartisan and medical consensus for Medical Marijuana in Pennsylvania and many other states, I am disturbed to know that you are actively pursuing a change in federal law to go after medical marijuana suppliers.

We do not need the federal government getting in the way of Pennsylvania’s right to deliver them relief through our new medical marijuana program.

Your action to undo the protections of the Rohrabacher-Farr amendment, which prevents the use federal funds to disrupt states’ efforts to implement “their own State laws that authorize the use, distribution, possession or cultivation of medical marijuana” is misguided.

If you seek to further disrupt our ability to establish a legal way to deliver relief of medical marijuana to our citizens, I will ask the Attorney General of Pennsylvania to take legal action to protect our residents and state sovereignty.

Sincerely,

Governor Tom Wolf

Attorney General Jeff Sessions Photo by Gage Skidmore

Attorney General Jeff Sessions
Photo by Gage Skidmore

This comes in response to a recently revealed private letter that Jeff Sessions sent to Congressional leadership requesting that the DOJ be permitted to target and prosecute state-licensed medical cannabis facilities, currently prohibited by a spending rider known as the Rohrabacher-Blumenauer amendment.

“I believe it would be unwise for Congress to restrict the discretion of the Department to fund particular prosecutions, particularly in the midst of an historic drug epidemic and potentially long-term uptick in violent crime,” Sessions wrote, “The Department must be in a position to use all laws available to combat the transnational drug organizations and dangerous drug traffickers who threaten American lives.”

Jeff Sessions actually seems to believe that lawful medical marijuana patients, i.e. sick people, are causing the violent crime and contributing to transnational drug trafficking.

Deputy Attorney General Rod Rosenstein was questioned about federal marijuana policy during a Senate Judiciary Committee hearing earlier this week and he brought up current DOJ policy and left the door wide open to a potential crackdown.

“Jim Cole tried to deal with it in that memorandum and at the moment that memorandum is still in effect. Maybe there will be changes to it in the future but we’re still operating under that policy which is an effort to balance the conflicting interests with regard to marijuana,” stated Rosenstein, “So I can assure you that is going to be a high priority for me as the U.S. Attorneys come on board to talk about how to deal with that challenge in the states that have legalized or decriminalized marijuana, whether it be for recreational or medical use…”

The Cole Memo, is a Justice Department memorandum, authored by US Deputy Attorney General James Cole in 2013 to US attorneys in all 50 states directs prosecutors not to interfere with state legalization efforts and those licensed to engage in the plant’s production and sale, provided that such persons do not engage in marijuana sales to minors or divert the product to states that have not legalized its use, among other guidelines.

But while the Justice Department contemplates its next move, Wolf and other state politicians are taking action. Recently, Washington Gov. Jay Inslee (D), Colorado Gov. John Hickenlooper (D), Oregon Gov. Kate Brown (D) and Alaska Gov. Bill Walker (I) issued a letter to the new U.S. Attorney General and to Secretary of Treasury Mnuchin calling on them to uphold the Obama Administration’s largely ‘hands off’ policies toward marijuana legalization, as outlined in the Cole Memo.

“Overhauling the Cole Memo is sure to produce unintended and harmful consequences,” the governors wrote. “Changes that hurt the regulated market would divert existing marijuana product into the black market and increase dangerous activity in both our states and our neighboring states.”

Click here to send a message to your member of Congress to urge them to force the Department of Justice to respect state marijuana laws and then visit http://norml.org/act to support other efforts in your state and federally.

PA resident? Click here to send a message to your state lawmakers to support the effort to decriminalize marijuana in the Keystone State.

Study: No Increase In Problematic Cannabis Use Following Passage Of Medical Marijuana Laws

no_marijuanaThe enactment of medical marijuana laws is not associated with increased rates of problematic cannabis use, according to data published online in the journal Addiction.

Columbia University investigators assessed cannabis use trends in states in the years following the passage of medicalization. They reported “no significant change in the prevalence of past-month marijuana use among adolescents or young adults (those ages 18 to 25)” following legalization. They also found no evidence of increased cannabis abuse or dependence by either young people or adults. States with largely unregulated medical programs were associated with increased self-reported use by adults age 26 and older, but states with stricter programs were not.

The study’s findings are consistent with those of numerous other papers reporting no uptick in youth marijuana use or abuse following medical marijuana regulation, including those here, here, here, here, here, and here. The findings contradict those of a recent, widely publicized paper in JAMA Psychiatry which speculated that medical marijuana laws may increase the prevalence of cannabis use disorder among adults.

An abstract of the study, “Loose regulation of medical marijuana programs associated with higher rates of adult marijuana use but not cannabis use disorder,” is online here.

Weekly Legislative Update 6/10/17

revolutionbumperWelcome to this week’s edition of the NORML legislative roundup!

First off, apologies to weekly readers for skipping last week’s update. We held a NORML Legal Committee seminar in Colorado about tactics to continue the fight against prohibition and protect those facing jail and other adverse ramifications of prohibition. You can watch NORML’s Executive Director give the opening welcome HERE and click here to read a write up on it in The Denver Post’s Cannabist HERE.

In the last two weeks, four pieces of legislation that we are supportive of went into law:

Colorado
Senate Bill 17 adds “stress disorders” (PTSD) to the list of debilitating conditions for which a physician may recommend cannabis.

Maryland
House Bill 379 / Senate Bill 949 went into effect May 27 to permit those who received a criminal marijuana possession conviction prior to October 1, 2014, to seek expungement of their records.

Often minor marijuana possession offenders, many of them young people, face the lifelong penalties and stigma associated with having a record, even when the state no longer considers simple possession to be a crime.

Nevada
Assembly Bill 135 eliminates statutes criminalizing the operation of a motor vehicle if a driver has detectable levels of carboxy THC in his/her urine. Carboxy-THC is an non-psychoactive waste product of THC that may be present for days or even weeks post-abstinence. It’s presence in urine is not correlated with psychomotor impairment.

While passage of AB 135 is a step in the right direction, further legislation will continue to be necessary in order to amend Nevada’s traffic safety laws in a manner that no longer inadvertently criminalize responsible adult marijuana consumers in regards to blood testing.

Vermont
SB 16 permits physicians for the first time to recommend medical marijuana to patients with post-traumatic stress, Crohn’s disease, or Parkinson’s disease. The measure also allows physicians to immediately issue medical cannabis recommendations for patients suffering from cancer, a terminal illness, or under hospice care supervision.

Unfortunately, in Montana, SB 333, was signed into law to amend the state’s medical cannabis program, I-182, which voters passed in November.

The measure establishes various rules and regulations regarding the operation of cannabis dispensaries, production facilities, and testing labs. It does not amend the expanded list of qualifying conditions enacted by I-182. However, SB 333 does impose new taxes on medical marijuana gross sales. NORML opposes taxes of medical cannabis. It also reduces the number of seedlings qualified patients are permitted to possess at home from 12 to no more than four. It also imposes limits regarding the total harvest of cannabis permitted per patient.

Following are the bills from around the country that we’ve tracked this week and as always, check http://norml.org/act for legislation pending in your state.

Don’t forget to sign up for our email list and we will keep you posted as these bills and more move through your home state legislature and at the federal level.

Thanks for all you do and keep fighting,
Justin

Priority Alerts
Federal
Join The Caucus: With public support for reforming marijuana laws at an all time high, Reps. Earl Blumenauer (D-OR), Dana Rohrabacher (R-CA), Jared Polis (D-CO), and Don Young (R-AK) earlier this year formed the Congressional Cannabis Caucus to develop and promote sensible cannabis policy reform and work to ease the tension between federal and state cannabis laws.

Click here to email your Member of Congress to urge them to join the Congressional Cannabis Caucus

California
Legislation is pending, Assembly Bill 1578, to try and limit potential federal interference in the state’s marijuana regulatory laws.

The bill states, “This bill would prohibit a state or local agency, as defined, from taking certain actions without a court order signed by a judge, including using agency money, facilities, property, equipment, or personnel to assist a federal agency to investigate, detain, detect, report, or arrest a person for commercial or noncommercial marijuana or medical cannabis activity that is authorized by law in the State of California and transferring an individual to federal law enforcement authorities for purposes of marijuana enforcement.”

The majority of Californians desire a legally regulated marijuana market. Passage of this act will limit state or local agencies from working with the federal government to undermine these regulations.

Update: AB 1578 passed the Assembly on June 1 and now moves to the Senate for consideration.

CA resident? Click here to send a message to your state Senator in support of this effort. 

Louisiana
SB 35 provides explicit exemptions from arrest and prosecution for persons lawfully in possession of medical marijuana.

Presently, state regulators are finalizing rules and regulations governing its nascent medical cannabis program, which seeks to permit the production, dispensing, and use of non-herbal preparations of cannabis for qualified patients. Passage of SB 36 amends various criminal statutes to assure that those involved in the program are not inadvertently subject to criminal liability.

Specifically, it provides immunity from arrest for those enrolled in the program who engage in activities related to the purchase or transportation of medical marijuana related products or paraphernalia. It provides further legal protections for pharmacies, producers, and testing laboratories engaged in medical cannabis related activities.

Update: House members amended and passed SB 35 by a vote of 74 to 21 on June 5. Senate members approved the House changes on June 6. The reconciled bill was transmitted to the Governor.

LA resident? Click here to send a message to the Governor in support of SB 35. 

New Hampshire
After nearly a decade of frustration, 2017 is finally the year that New Hampshire voters successfully see marijuana possession decriminalized.

HB 640, will amend criminal penalties for marijuana possession is pending in the House, where lawmakers have overwhelmingly supported such efforts for eight years in a row. However, legislators this year are hopeful that, for the first time, they also have sufficient votes to also clear the Senate.

Update: The House concurred with the amended Senate bill on June 1 and the bill will soon be transmitted to the Governor.

NH resident? Click here to send a message to the Governor thanking him for his support of decriminalization. 

Rhode Island
Sponsors have announced plans to amend their legislation in a manner that would legalize the possession of up to one ounce of cannabis, effective July 1, 2018. The amended legislation would also establish an advisory committee to issue a report to the General Assembly by January 1, 2018 with recommendations regarding how best to establish a system for taxing and regulating marijuana in Rhode Island. Sen. Miller said, “We are prepared to compromise in a significant way, but there must be progress on the issue this year. Our proposal balances the will of the majority of voters who want marijuana to be legal for adults while respecting colleagues who want to slow things down and get the regulations right.”

RI resident? Click here to send a message to your elected officials in support of this effort. 

Other Actions to Take

Massachusetts
Legislation is pending before the House, H 113, to prohibit employers from discriminating against patients who legally consume marijuana during non-work hours. Additional legislation, H 2385, would expand protections for medical marijuana patients so that they may not be discriminated against with regard to housing, higher education, and child custody issues.

Changes in the legal status of marijuana has not been associated with any adverse changes in workplace safety. In fact, a pair of studies from 2016 find that legalization is associated with greater workforce participation and with fewer workplace absences. Most recently, the National Academies of Sciences just-released marijuana and health report found “insufficient evidence” to support an association between cannabis use and occupational accidents or injuries.

MA resident? Click here to send a message to your elected officials in support of this effort. 

New Hampshire
Legislation is pending in the New Hampshire House, HB 215, to establish a commission to study the legalization, regulation, and taxation of marijuana.

Police in New Hampshire arrest some 2,900 individuals annually for simple marijuana possession offenses. The continued criminalization of adult marijuana use is out-of-step with the views of New Hampshire adults, 62 percent of whom now endorse legalizing and regulating cannabis, according to a 2016 WMUR Granite State Poll.

Update: The House has adopted the Senate changes. The bill is expected to be transmitted to the Governor imminently.

NH resident? Click here to send a message to the Governor urging him to sign HB 215

Additionally, multiple bills are pending to expand the pool of patients eligible to qualify for medical marijuana therapy.

In particular, these measures would permit patients with conditions like chronic pain and post-traumatic stress to obtain legal access to marijuana.

NH resident? Click here to contact your elected officials to support patients. 

New York
A pair of bills are pending in the Senate to expand patients’ access to medical cannabis.

Senate Bill 6092 expands the pool of patients eligible for medical cannabis access to include those with Alzheimer’s disease, lupus, rheumatoid arthritis and a number of other debilitating diseases. It also removes arbitrary caps imposed on the amount of THC permitted in oral products.

Senate Bill 6308 allows for additional cannabis providers to operate in the state in order to improve patients’ access.

NY resident? Click here to send a message to your lawmakers in support of these bills. 

Rhode Island
SB 176 is currently pending in the Rhode Island Senate. It amends the state’s Medical Marijuana Act, which currently only permits three medical marijuana dispensaries to operate in the entire state, to permit regulators to license up to six total dispensaries.

In recent years, the total number of registered medical cannabis patients in Rhode Island has nearly doubled to more than 17,000 people. It is necessary for regulators to license additional dispensaries in order to keep up with this increased demand.

RI resident? Click here to send a message to your lawmakers in support of this effort. 

Benefits of medical marijuana for treatment of epilepsy examined

Although cannabis had been used for many centuries for treatment of seizure disorders, medical use became prohibited in the 20th century. However, with the loosening of laws regarding medical marijuana, research and clinical use of marijuana-derived substances are increasing. This has prompted the publishing of an in-depth assessment of the potential of cannabinoids for the effective treatment of epilepsy. Cannabinoids are components of the cannabis plant.

Las Vegas NORML Ramps up Advocacy Efforts

1294bbf7-8ed0-450d-9f98-5f7fd0090ae4With state lawmakers in Nevada quickly approaching their fast-tracked deadline of July 1st to implement the state’s new adult-use marijuana program, NORML is focused on ramping up our activism efforts in Las Vegas!

Over the past two months, we’ve been busy planning, attending legislative hearings, tabling at events, doing community outreach, volunteering at our local community garden, and more to get the word out about our new chapter, and post-legalization activism in Las Vegas.

So far during the 2017 legislative session, there have been several key pieces of legislation introduced. One of the most important bills that we’re currently pushing is Senator Tick Segerblom’s SB 329, which would safeguard many protections for marijuana patients and the legal marijuana industry. These protections include re-establishing patient grow rights, allowing medical marijuana research facilities, allowing marijuana establishments to be organized as a corporation, and adds PTSD as a qualifying condition for medical marijuana.

Another important piece of legislation that we’re watching closely is SB 236; if adopted by lawmakers, this legislation would permit social use marijuana clubs across Nevada. With the issue of social marijuana consumption quickly becoming a main issue for marijuana advocates in post-legalization states, Las Vegas NORML believes this legislation would be the first step in providing marijuana consumers with a safe and legally defined space to responsibly consume their legally purchased marijuana.

To learn more, join us for our next meeting on Tuesday, May 23rd where we’ll discuss the various pieces of marijuana-related legislation in Nevada! Get involved and invite your friends!

17159166_1914499645452277_4695175184675219897_o

Creating a Space for Marijuana Activism

We’re at a crucial time in the legislative session, so we need our members and supporters to speak-up for Nevada marijuana consumers by urging their representatives to support marijuana-related legislation. To help facilitate this, Las Vegas NORML has organized a postcard writing party! This will give everyone a chance to share their personal stories and reasons why they support marijuana legislation with their lawmakers.

We also have two guest speakers from Nevada’s marijuana industry that will be joining us: DB Labs and Sahara Wellness. DB Labs will be educating our members on marijuana testing in Nevada, and Sahara Wellness will be sharing their story of helping patients in the community. Plus we’ll have event sign-ups, membership packages, legislative updates, and even FREE SNACKS! Who can say no to that?

Be sure to RSVP using our Facebook Event Page, and invite all of your friends in Las Vegas!

For more information on Las Vegas NORML, please find us on Facebook, Twitter, Instagram, or email us at LasVegasNORMLchapter@gmail.com.

Delaware Legislature Advances Full Legalization To Full House Vote

norml-bumper-sticker2Never in the history of Delaware has a marijuana legalization bill passed out of committee – yet these days NORML chapters throughout the country are writing a new future.

After organizing of heroic proportions, Delaware NORML has driven the phone calls, lead the meetings, organized the town halls, and created momentum so strong that yesterday, HB 110, to legalize and establish a regulatory system for distribution, passed committee 7 to 2.

Senate Majority Whip Margaret Rose Henry, the author of the state’s medical marijuana legislation and sponsor of HB 110’s Senate companion legislation, said at a recent Medical Marijuana Act Oversight Committee meeting “Education is suffering. Revenue from legalizing marijuana could help struggling schools and seniors, among other causes and close major budget deficits in Delaware.”

According to recent polling data compiled by the University of Delaware, sixty-one percent of state voters favor legalizing marijuana.

DE resident? Click here to send a message to your lawmakers to support marijuana legalization in your state. 

Got a friend in Delaware? Send them this information and hopefully you will be more incentivized to go visit them in the near future.

Want to support the critical work of Delaware NORML? Make a contribution to further their efforts by clicking here.

Visit https://www.denorml.org/ and make sure to follow Delaware NORML on Facebook and Twitter!

Texas: HB 2107 Stalls at the Deadline – A Letter from Texas NORML Executive Director

Fellow Texans,

It is with a heavy heart that I write you. I must inform you that the deadline for a bill to be put on the House Agenda for the floor expired last night at 10pm. While HB 81 did make it on to the agenda before the deadline, HB 2107 did not.

This was due to the paperwork not being completed for it’s enrollment in calendars with enough time, completed less than 3 hours before the deadline to be placed on the agenda. With no special Calendars meeting called to hear it’s addition, HB 2107 was not able to progress and is no longer a viable option in it’s form. However, it’s two main authors, Rep Lucio III and Rep Isaac, have promised to continue to look for avenues to codify protections for patients as this legislative session continues. You can also read this touching letter from them.Texas NORML will diligently support any attempts made to enact protections for patients in the upcoming weeks.

Our thoughts are with the many patients, caregivers and practitioners in the state that are effected by this disappointment. Times like these are very difficult and we are all still working to process this.

With that in mind, I would like to share some silver linings that have come from the historic actions taken to enact HB 2107 that I hope help soften the blow.

Texas has never previously held a committee vote on a whole plant medical cannabis bill. We were able to hold our most powerful and effective hearing yet which ended in a 7-2 vote that we know have on the record for the first time. It is also remarkable to note that the Chair put the bill up for a vote out of turn and knowing he would vote against it. This is not a regular occurrence.

A historic 70+ legislators signed up as coauthors on the bill in the 36 hour periodafter the hearing. 28 of those were Republicans. 4 of the 5 Doctors in the Houseare also included in the coauthor list. We have gone from a handful of legislative supporters to unprecedented numbers! Numbers that would have given HB 2107 the votes to pass. So we must diligently work to keep each one of these allies.

With that many legislators vested, safe access to medical cannabis becomes a significant campaign talking point. It will be important the we check back in on the basics when the interim begins and prepare for the most important campaign season of medical cannabis’ history. We will of course have a new Texas NORML Marijuana Policy Voter Guide and Voting Appendix.

It is important that we keep our lobbying efforts alive and sustain the work we are doing at the Capitol and across the state. There will be major opportunities in front of us that we must be ready to capitalize on.

We learned a lot. We are carbon pressed to diamonds. We must continue to slice away at prohibition!

Please take a moment to CALL or EMAIL your support for HB 81, so that we can work to remove the criminal penalty for possession of one ounce or less! It is imperative that we accomplish this by midnight on Thursday, the day the bill is scheduled.

Jax Finkel

Executive Director
Texas NORML
The problem is the law, not the plant.
Re-legalize!

Weekly Legislative Update 5/6/17

revolutionbumperWelcome to this week’s edition of the NORML legislative roundup!

The biggest story this week in the marijuana world was the inclusion of the Rohrabacher-Blumenauer language (Section 537) in the omnibus spending package to prevent the Department of Justice from interfering with lawful state-regulated medical marijuana consumers and businesses.

In a signing statement by President Trump, expressed that he “will treat this provision consistently with my constitutional responsibility to take care that the laws be faithfully executed” when it comes to Section 537. The lack of clarity is disturbing and casts doubt on whether his administration and Attorney General Jeff Sessions will honor the enforcement restrictions. In the past, the courts have upheld this tactic of Congress legislating through the appropriations process, however it will ultimately take a bill to end this tension between the federal and state laws, not just temporary spending riders.

Marijuana Big Talks Speaker Lineup FINAL 5.3 copyAlso this week, Representative Jared Polis held an event in the foyer of the Rayburn House Office Building solely focused on marijuana policy. Speakers included Boulder County D.A. Stan Garnett and former Colorado NORML Executive Director Rachel Gillette.

For the whole morning, the halls of Rayburn echoed with the words of cannabis reformers declaring the need for sensible policies on marijuana ranging from the need for 280E tax reform to an end to the delusional thought that a southern boarder wall will stop the drug trade.

At the state level, this has been a very active week for marijuana reformers as additional states near the end of their legislative calendars. Progress has been made from Texas moving forward to establish a medical marijuana program to Vermont inching closer towards outright legalization. Yet with the end of the Florida legislative session, the House and Senate were unable to come to a compromise as how to implement Amendment 2 and now the rule making process will be left up to the Florida Department of Health.

Following are the bills from around the country that we’ve tracked this week and as always, check http://norml.org/act for legislation pending in your state.

Don’t forget to sign up for our email list and we will keep you posted as these bills and more move through your home state legislature and at the federal level.

Thanks for all you do and keep fighting,
Justin

Priority Alerts

Federal

Join The Caucus: With public support for reforming marijuana laws at an all time high, Reps. Earl Blumenauer (D-OR), Dana Rohrabacher (R-CA), Jared Polis (D-CO), and Don Young (R-AK) earlier this year formed the Congressional Cannabis Caucus to develop and promote sensible cannabis policy reform and work to ease the tension between federal and state cannabis laws.

Click here to email your Member of Congress to urge them to join the newly created Congressional Cannabis Caucus

New Hampshire

After nearly a decade of frustration, 2017 may finally be the year that New Hampshire voters successfully see marijuana possession decriminalized.

HB 640, sponsored by 6 Republicans and 6 Democrats, will amend criminal penalties for marijuana possession is pending in the House, where lawmakers have overwhelmingly supported such efforts for eight years in a row. However, legislators this year are hopeful that, for the first time, they also have sufficient votes to also clear the Senate.

Update: Governor Chris Sununu has reiterated his support for decriminalizing marijuana.

NH resident? Click here to send a message to your lawmakers telling them to act on decriminalization this year. 

Texas

Legislation to authorize the possession, production, and distribution of medical marijuana and marijuana-infused products to qualified patients. Patients would receive cannabis through a network of private dispensaries and operators, similar to pharmacies, regulated under “strict guidelines” by the Texas Department of Public Safety.

Update: HB 2107 had a hearing on May 2 and after powerful targeted testimony, the number of cosponsors for the bill jumped from 5 to 75. Later in the week, the Texas House of Representatives Committee on Public Health approved HR 2107 on May 5 by a vote of 7-2. The bill will now be considered by the Calendars Committee to determine the date of the full House vote.

TX resident? Click here to send a message to your lawmakers and tell them to support the bill. 

Vermont

Legislation is pending, H.170, to eliminate civil and criminal penalties specific to the possession and cultivation of personal use quantities of marijuana by adults.

Update: The Senate has passed on May 5 an unrelated bill (S. 22) to include the provisions of H. 170. It maintains House approved language eliminating penalties for the possession and cultivation of personal use amounts of marijuana by July 2018, but also creates a new Marijuana Regulation Commission, to draft legislation by November 1, 2017 that “establishes a comprehensive regulatory and revenue system for an adult-use marijuana market that, when compared to the current illegal marijuana market, increases public safety and reduces harm to public health.” The commission’s bill would be ready for a vote by January 2018.

VT resident? Click here to send a message to your lawmakers and urge them to take swift action to pass the bill. 

Additional Actions to Take

Colorado

State officials in Colorado are considering legislation, SB 192, to protect the state’s adult use marijuana industry in case of a potential federal crackdown.

The bill would permit adult use growers and sellers to instantly reclassify their recreational marijuana inventory as medical marijuana “based on a business need due to a change in local, state, or federal law or enforcement policy.” In recent weeks, officials from the Trump administration have indicated that they may consider taking action against recreational marijuana providers, but that they will not likely move against state-licensed medical marijuana providers.

Update: House members approved SB 192 on May 3 by a vote of 58 to 5. Because of House amendments, the bill returns to the Senate, which must either re-approve the measure or seek reconciliation.

CO resident? Click here to contact your elected officials in support of this effort.

Louisiana

SB 35, introduced by Sen. Yvonne Colomb, provides explicit exemptions from arrest and prosecution for persons lawfully in possession of medical marijuana.

Presently, state regulators are finalizing rules and regulations governing its nascent medical cannabis program, which seeks to permit the production, dispensing, and use of non-herbal preparations of cannabis for qualified patients. Passage of SB 36 amends various criminal statutes to assure that those involved in the program are not inadvertently subject to criminal liability.

Specifically, it provides immunity from arrest for those enrolled in the program who engage in activities related to the purchase or transportation of medical marijuana related products or paraphernalia. It provides further legal protections for pharmacies, producers, and testing laboratories engaged in medical cannabis related activities.

Update: Members of the Senate Judiciary Committee voted without opposition to move SB 35 to the Senate floor.

LA resident? Click here to contact your elected officials in support of this effort.

Maine

Legislation is pending to expedite the retail sale of marijuana products to those over the age of 21.

LD 1448 and LD 1491 would permit licensed medical cannabis dispensaries the opportunity to “sell limited marijuana retail products to a person who is 21 years of age or older.”

A majority of voters in November approved an initiated measure to permit the possession, production, and retail sale of marijuana and marijuana-infused products. However, emergency legislation signed into law in January delays the implementation of regulations overseeing the commercial production and retail sale of marijuana until at least February 1, 2018.

Passage of these measures would allow dispensaries to engage in marijuana sales ahead of this date.

ME resident? Click here to contact your elected officials in support of this effort.

New Hampshire

Multiple bills are pending before lawmakers to expand the pool of patients eligible to qualify for medical marijuana therapy.

In particular, these measures would permit patients with conditions like chronic pain and post-traumatic stress to obtain legal access to marijuana.

Update: Members of the Senate Health and Human Services Committee on May 4 passed HB 160 out of Committee.

NH resident? Click here to contact your elected officials in support of this effort.

New York

Legislation is moving forward, A. 7006, to allow patients with post-traumatic stress eligible for medical cannabis therapy.

New York is one of the only states with a medical marijuana program that does not allow patients with PTSD access to medical cannabis.

Update: The New York Assembly passed A 7006 on May 2. The bill now awaits action by the Senate. Governor Andrew Cuomo says that he is open to expanding the state’s medical cannabis program to include patients with PTSD.

NY resident? Click here to urge your lawmakers to support this effort.

Vermont

If approved, SB 16 would permit physicians for the first time to recommend medical marijuana to patients with post-traumatic stress, Crohn’s disease, or Parkinson’s disease. The measure also allows physicians to immediately issue medical cannabis recommendations for patients suffering from cancer, a terminal illness, or under hospice care supervision.

Update: Members of the House gave preliminary approval SB 16 on May 1. Once a final vote is recorded, the measure will be transmitted to the Governor’s office.

VT resident? Click here to urge the Governor to sign SB 16.

Congress’ 2017 Budget Plan Reauthorizes Protections For State Medical Cannabis Programs

thumbs_upSpending legislation approved by Congress and signed into law reauthorizes language protecting state-sanctioned medical marijuana and industrial hemp programs.

Specifically, Section 537 of the Consolidated Appropriations Act of 2017, states that no federal funds may be appropriated to “prevent any [state] from implementing their own laws that authorize the use, distribution, possession, or cultivation of medical marijuana..” That language, initially passed by Congress in 2014, is now known as the Rohrabacher-Blumenauer amendment.

A similarly worded amendment protecting state-sponsored hemp programs was also reauthorized.

Both amendments will remain in effect until September 30, 2017, at which time members of Congress will once again need to either reauthorize the language or let the provisions expire.

Forty-six states now recognize the therapeutic use of either cannabis or cannabidiol derived products. Thirty states recognize hemp as an industrial crop.

Eight States regulate the adult use, production, and sale of marijuana. Non-medical, retail marijuana businesses operating in these states are not protected by these amendments and still remain vulnerable to federal interference or prosecution. In February, White House Press Secretary Sean Spicer publicly said that the administration was considering engaging in “greater enforcement” of federal anti-marijuana laws in these jurisdictions.

Congressional Protections For Legal State Medical Marijuana Programs Expected To Be Extended

3410000930_95fc2866fa_zWe welcome the extension and expansion of critical marijuana policy provisions through September 30 in the proposed fiscal year 2017 omnibus funding legislation.

The decision to reauthorize the Rohrabacher-Blumenauer amendment language illustrates both compassion and common sense when it comes to marijuana policy. Now, the majority of states and over 90 percent of the public approves of the use of marijuana as a medicine and Congress should not stand in the way of these reforms.

Congress deciding to maintain protections for state-sanctioned medical marijuana programs in the era of a Department of Justice being led by Attorney General Jeff Sessions means that patients ailing from conditions that range from cancer to PTSD can breathe a temporary sigh of relief. Once approved, states will be able to continue to service and implement these programs without fear of federal incursion until September 30 of this year.

Yet, this action is only a stopgap measure at best. Ultimately, Congress needs to amend federal law in a manner that comports with the available science, public opinion, and with America’s rapidly changing cultural and legal landscape. Such action includes removing cannabis from the Controlled Substances Act so that states possess the flexibility to engage in their own marijuana regulatory policies how best they see fit.

The text in the omnibus funding legislation is:
Page 230 – “SEC. 537. None of the funds made available in this Act to the Department of Justice may be used, with respect to any of the States of Alabama, Alaska, Arkansas, Arizona, California, Colorado, Connecticut, Delaware, 25 Florida, Georgia, Hawaii, Illinois, Iowa, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, Wisconsin, and Wyoming, or with respect to the District of Columbia, Guam, or Puerto Rico, to prevent any of them from implementing their own laws that authorize the use, distribution, possession, or cultivation of medical marijuana.

 

Weekly Legislative Update 4/29/17

revolutionbumperWelcome to this week’s edition of the NORML legislative roundup!

At the federal level, it is important to highlight two key developments pertaining to established marijuana consumers, businesses, and regulatory structures.

First, the protections for lawful medical marijuana patients and businesses from the Department of Justice provided by the Rohrabacher-Farr budget amendment was temporarily expended through May 5th and we are working of ensuring that that will be a part of any budget deal for the rest of the fiscal year. In the last week alone, NORML members sent over 24,000 messages to members of Congress and we plan to keep the pressure up. If you have not already, click here to send a message to your elected lawmakers. 

Second, on April 27, Representative Ed Perlmutter (D-CO) introduced The Secure and Fair Enforcement Banking Act (SAFE Banking Act), to provide access to banking services to end the practice of marijuana businesses being forced to pay their employees, rent, taxes, and other associated costs in cash. At the end of the day, no industry can operate safely, transparently, or effectively without access to banks or other financial institutions.

Following are the bills from around the country that we’ve tracked this week and as always, check http://norml.org/act for legislation pending in your state.

Don’t forget to sign up for our email list and we will keep you posted as these bills and more move through your home state legislature and at the federal level.

Thanks for all you do and keep fighting,
Justin

Priority Alerts

Federal
Protect Patients: Since 2014, members of Congress have passed annual spending bills that have included a provision protecting those who engage in the state-sanctioned use and dispensing of medical cannabis from undue prosecution by the Department of Justice. The amendment, known as the Rohrabacher-Farr Amendment, maintains that federal funds can not be used to prevent states from “implementing their own state laws that authorize the use, distribution, possession or cultivation of medical marijuana.”

On April 28, Congress re-authorized the amendment as part of a one week spending package, House Resolution 99. This bill extends federal funding through May 5 2017, at which time the measure — and the Rohrabacher-Farr Amendment — will expire.

Click here to message your members of Congress to protect state medical marijuana and their patients. 

Banking Access: A bipartisan coalition of more than two dozen co-sponsors have introduced legislation in Congress, The Secure and Fair Enforcement Banking Act (SAFE Banking Act), HR 2215, to allow state-licensed marijuana-related businesses to engage freely in relationships with banks and other financial institutions.

If enacted, banks would no longer face the threat of federal sanction for working with marijuana-related businesses and entrepreneurs.

Click here to send a message to your member of Congress to support access to banking for state-compliant marijuana businesses.

Join The Caucus: With public support for reforming marijuana laws at an all time high, Reps. Earl Blumenauer (D-OR), Dana Rohrabacher (R-CA), Jared Polis (D-CO), and Don Young (R-AK) earlier this year formed the Congressional Cannabis Caucus to develop and promote sensible cannabis policy reform and work to ease the tension between federal and state cannabis laws.

Click here to email your Member of Congress to urge them to join the newly created Congressional Cannabis Caucus

New Hampshire
After nearly a decade of frustration, 2017 was looking like it would finally be the year that New Hampshire voters successfully see marijuana possession decriminalized. Yet, stagnation has descended upon the state Senate and now State Sen. Bradley is pushing for an amendment that would remove the decriminalization paragraph (and thus the whole point) from the bill.

NH resident?  Click here to send a message to your state Senators and tell them to quit stalling and decriminalize marijuana now. 

Florida

On November 8th, more than 71 percent of Florida voters decided in favor of the constitutional amendment, Amendment 2, to allow for the licensed production, use, and dispensing of medical cannabis to patients with a doctor’s recommendation. However, state politicians are contemplating legislative efforts to amend the law in a manner that violates both its spirit and intent.

Update: Members of the Senate Appropriations Committee approved SB 406 on April 25.

FL resident? Send a message to your lawmakers telling them not to guy Amendment 2. 

Pennsylvania 
Under current law, possession of up to 30 grams is third-degree misdemeanor that carries up to 30 days in jail, a $500 fine and a driver’s license suspension if convicted by a plea or trial.

House Bill 928 amends state law so that first and second marijuana possession offenses (up to 30 grams) are reduced from misdemeanor offenses to a summary offense, punishable by a fine only, and had a hearing earlier this week.

PA resident? Click here to send a message to your state lawmakers telling them it is time to decriminalize marijuana. 

Texas
HB 2107, which authorizes the possession, production, and distribution of medical marijuana and marijuana-infused products to qualified patients. Patients would receive cannabis through a network of private dispensaries and operators, similar to pharmacies, regulated under “strict guidelines” by the Texas Department of Public Safety.

A hearing is scheduled for this week on May 2.

TX resident? Click here to send a message to your lawmakers now to support patients and medical marijuana in Texas. 

Other Actions to Take

California
Legislation is pending, Assembly Bill 1578, to try and limit potential federal interference in the state’s marijuana regulatory laws.

The bill states, “This bill would prohibit a state or local agency, as defined, from taking certain actions without a court order signed by a judge, including using agency money, facilities, property, equipment, or personnel to assist a federal agency to investigate, detain, detect, report, or arrest a person for commercial or noncommercial marijuana or medical cannabis activity that is authorized by law in the State of California and transferring an individual to federal law enforcement authorities for purposes of marijuana enforcement.”

CA resident? Click here to send a message to your lawmakers in support of this bill.

Colorado
Legislation is pending to prohibit public employees from assisting federal agents in “arresting a Colorado citizen for committing an act that is a Colorado constitutional right.” Such acts would include the production and sale of marijuana.

Update: Members of the House voted 56 to 7 on April 26 in favor of the bill. It now awaits action from the Senate.

CO resident? Click here to send a message to your state Senator to support this effort.

Also, Legislation to make patients with post-traumatic stress eligible for medical cannabis therapy awaits action from Gov. John Hickenlooper.

Members of the House approved the bill by a vote of 39 to 25. Senate members approved it by a vote of 32 to 2.

CO resident? Click here to send a message to the Governor is support of this effort.

Iowa
In a last minute deal by Iowa state lawmakers, both chambers passed an amended version of HF 524 on the final day of the legislative session. The measure expands the state’s existing CBD exemption law, which was set to sunset this year, and expands it. Specifically, HF 524 permits patients with various qualifying conditions, Parkinson’s disease, cancer, multiple sclerosis, seizures, AIDS and HIV, Crohn’s disease and Amyotrophic Lateral Sclerosis, to possess CBD with up to 3% THC. The bill also seeks to establish regulations for the manufacturing and dispensing of CBD products within the state. The bill now goes to Governor Terry Branstad (R) for his signature or veto.

IA resident? Click here to send a message to Gov. Branstad to sign HF 524. 

Vermont
Legislation is pending, H.170, to eliminate civil and criminal penalties specific to the possession and cultivation of personal use quantities of marijuana by adults, yet by a vote of 21-9, senators amended H 170 to include a full-scale system of taxed and regulated cannabis sales.

VT resident in favor of legalization? Click here to send a message to your lawmakers in support of this effort. 

Additionally, legislation is pending, SB 16, to expand the pool of patients eligible for cannabis therapy.

If approved, SB 16 would permit physicians for the first time to recommend medical marijuana to patients with post-traumatic stress, Crohn’s disease, or Parkinson’s disease. The measure also allows physicians to immediately issue medical cannabis recommendations for patients suffering from cancer, a terminal illness, or under hospice care supervision.

Update: Members of the House Human Services Committee voted 10-0 in favor of SB 16 on April 27.

VT resident? Click here to send a message to your lawmakers in support of this effort. 

Washington
House and Senate lawmakers have approved legislation, SB 5131, to expand medical cannabis access. The measure now awaits action from Gov. Jay Inslee.

Senate Bill 5131 permits qualified patients and/or caregivers ages 18 and older to purchase immature cannabis plants, seeds, or clones from state-licensed dispensaries. Marijuana cooperatives may also purchase seeds from a licensed marijuana producer.

WA resident? Click here to send a message to Gov. Inslee in support of SB 5131.

 

 

Last Chance To Protect Medical Marijuana Patients and Providers From Jeff Sessions

Medical marijuana

Update: Congress passed a one-week continuing resolution to maintain the current federal spending levels with the Rohrabacher-Farr amendment included, meaning state medical marijuana patients and businesses will remain protected from Attorney General Jeff Sessions and the Department of Justice until May 5.

Today is the final day that Congress has to pass a short-term budget to fund the federal government and it’s up to us to make sure that lawmakers reauthorize the Rohrabacher-Farr amendment. This critical amendment stops Jeff Sessions’ Department of Justice from targeting state-sanctioned medical marijuana patients, growers, caregivers, and providers.

Click here now to tell your member of Congress to Stop Sessions from going after marijuana.

94% of US voters support legal access to medical marijuana. Congress needs to understand that this is a mandate that is non-negotiable.

We cannot give one inch of our hard fought victories when we still have so far to go.

Take action today to protect our gains and to keep in place programs that millions of patients have come to rely upon. Tomorrow we continue our fight to legalize marijuana nationwide.

Click HERE now to make your voice heard!

Background:

Since 2014, members of Congress have passed annual spending bills that have included a provision protecting those who engage in the state-sanctioned use and dispensing of medical cannabis from undue prosecution by the Department of Justice. The amendment, known as the Rohrabacher-Farr Amendment, maintains that federal funds can not be used to prevent states from “implementing their own state laws that authorize the use, distribution, possession or cultivation of medical marijuana.”

In December, Congress re-authorized the amendment as part of a short term spending package, House Resolution 2028. This bill extends federal funding through April 28, 2017, at which time the measure — and the Rohrabacher-Farr Amendment — will expire.

According to recently released nationwide survey data, the majority of Americans are on our side. A whopping 93 percent support the medical use of marijuana. Perhaps most importantly, 71 percent of voters — including strong majorities of Democrats, Republicans, and Independents — say that they “oppose the government enforcing federal laws against marijuana in states that have already legalized medical or recreational marijuana.”

Again, please contact your member of Congress right now to protect legal state medical marijuana patients and businesses. 

 

Login | Register

Copyright Top Nug © All Rights Reserved · Top Nug Theme by Ame

PIXSELL8 Pixel Count Remaining